Extended-release 7-day injectable buprenorphine was safe and tolerable for most patients who had minimal-to-mild opioid withdrawal, a nonrandomized trial found. Among 100 adult patients with ...

An early-stage randomized trial showed that yoga alongside standard buprenorphine therapy hastened opioid withdrawal recovery and improved autonomic regulation compared with buprenorphine alone.

Buprenorphine is a medication approved for pain and opioid dependence. New findings published in The American Journal on Addictions indicate that a transmucosal dose (which dissolves in the mouth) of ...

Please provide your email address to receive an email when new articles are posted on . Patients who participated in yoga sessions alongside usual care reached withdrawal stabilization 4.4 times ...

Adding yoga to standard care for opioid use disorder (OUD) may speed up recovery from opioid withdrawal and improve nervous system regulation, results from a new randomized clinical trial suggested.

Injectable, extended-release buprenorphine was deemed safe for patients experiencing minimal to mild opioid withdrawal (COWS scores 4-7), making the drug a viable and safe treatment option, according ...

A seven-day, extended-release version of buprenorphine — a treatment for opioid use disorder (OUD) that can reduce opioid use and overdose deaths — is safe and effective for people with OUD ...

A new study published in JAMA Network Open on May 7, 2026, engaged 42 national experts in hospital-based addiction treatment in a consensus-building process to develop best practices for ...